Regen BioPharma Inc (RGBP)
0.74
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Regen BioPharma Free Cash Flow: -0.4821M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.4821M |
| December 31, 2023 | -0.3258M |
| September 30, 2023 | -0.1739M |
| June 30, 2023 | -0.2358M |
| March 31, 2023 | -0.2725M |
| December 31, 2022 | -0.3382M |
| September 30, 2022 | -0.6069M |
| June 30, 2022 | -1.589M |
| March 31, 2022 | -1.529M |
| December 31, 2021 | -1.410M |
| September 30, 2021 | -1.131M |
| June 30, 2021 | -0.0639M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0057M |
| September 30, 2020 | 0.0186M |
| June 30, 2020 | -0.1183M |
| March 31, 2020 | -0.1856M |
| December 31, 2019 | -0.3075M |
| September 30, 2019 | -0.4818M |
| June 30, 2019 | -0.8105M |
| Date | Value |
|---|---|
| March 31, 2019 | -0.8246M |
| December 31, 2018 | -1.101M |
| September 30, 2018 | -1.578M |
| June 30, 2018 | -1.735M |
| March 31, 2018 | -2.071M |
| December 31, 2017 | -2.017M |
| September 30, 2017 | -1.894M |
| June 30, 2017 | -1.670M |
| March 31, 2017 | -1.664M |
| December 31, 2016 | -1.751M |
| September 30, 2016 | -1.672M |
| June 30, 2016 | -1.613M |
| March 31, 2016 | -1.590M |
| December 31, 2015 | -1.421M |
| September 30, 2015 | -1.193M |
| June 30, 2015 | -1.044M |
| March 31, 2015 | -0.8241M |
| December 31, 2014 | -0.7509M |
| September 30, 2014 | -0.7469M |
Free Cash Flow Range, Past 5 Years
-1.589M
Minimum
Jun 2022
0.0186M
Maximum
Sep 2020
-0.5024M
Average
-0.3166M
Median
Free Cash Flow Benchmarks
| CervoMed Inc | -7.450M |
| GlucoTrack Inc | -6.558M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.2093M |
| Cash from Financing (Quarterly) | 0.1629M |
| Free Cash Flow Per Share (Quarterly) | -0.0531 |
| Free Cash Flow to Equity (Quarterly) | -0.189M |
| Free Cash Flow Yield | -17.42% |